Once You Experience the 7th Annual MasterPsych Conference, All Other Conferences Will Seem Obsolete. Here’s Why:
Two Conference Tracks
The MasterPsych Conference is two conferences in one: the Adult Psychiatry track and the Child & Adolescent Psychiatry track.
If you wish to view both tracks, register now for the Platinum package and receive online access to both tracks for an entire year. Plus, the Platinum Package saves you $694!
In effect you have the benefit of two full conferences instead of just one while earning a lot of CME and Self-assessment credits.
Medical Update for the Psychiatrist
I believe that every psychiatrist should spend at least one day a year getting updated on developments in the rest of medicine. After all, many of our patients have multiple and chronic medical comorbidities that impact treatment plans.
Luckily, the MasterPsych Conference offers a Medical Update that also runs on two tracks: the Pediatric Medical Update and the Adult Medical Update. These Medical Updates are designed for psychiatrists to help address questions relevant to our field, such as, when to evaluate a patient’s medical condition and when to refer out, what impact those medical conditions may have on the patient’s psychiatric disorders and vice versa, and how all the medications prescribed by multiple physicians can interact and place the patient at risk.
Earn Up To 64 AMA PRA
Category 1 Credits™
Including 16 Self-Assessment Credits! Your tuition includes:
- 17 AMA PRA Category 1 Credits™ for the Adult Track core conference
- 17 AMA PRA Category 1 Credits™ for the Child & Adolescent core conference
- 7 AMA PRA Category 1 Credits™ for the Adult Medical Update
- 7 AMA PRA Category 1 Credits™ for the Pediatric Medical Update
- Adult core conference – Earn 8 AMA PRA Category 1 Credits™ including 8 ABPN®-approved Self-Assessment (SA) credits when you complete the optional SA test.
- Child core conference – Earn 8 AMA PRA Category 1 Credits™ including 8 ABPN®-approved Self-Assessment (SA) credits when you complete the optional SA test.
- Choose the platinum package and earn 64 AMA PRA Category 1 Credits™ including 16 ABPN®-approved Self-Assessment (SA) credits from this one conference!
If the 7th Annual MasterPsych Conference sounds promising to you, please take a few moments to register now. You won’t regret your decision!
Note that many employers, group practices and training programs will reimburse you for the costs of these Category 1 CME activities, so be sure to ask!
Yours in living to the fullest,
Jack Krasuski, MD
Online Course v8, Original Release Date October 10, 2016, Termination Date October 5, 2019:
The PeerPoint Medical Education Institute designates this enduring material for a maximum of 64 AMA PRA Category 1 Credits™ including 16 Self-Assessment Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity has been planned and implemented in accordance with the Essentials and Standards of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of PeerPoint Medical Education Institute and American Physician Institute for Advanced Professional Studies, LLC. PeerPoint Medical Education Institute is accredited by the ACCME to sponsor continuing medical education for physicians.
The American Board of Psychiatry and Neurology has reviewed the 7th Annual MasterPsych Conference and has approved this program as a part of a comprehensive Self-Assessment Program, which is mandated by the ABMS as a necessary component of Maintenance of Certification.
Elias Aboujaoude, MD
- Clinical Professor of Psychiatry, Stanford University School of Medicine, Stanford, CA
- Director, Impulse Control Disorders Clinic, Stanford University School of Medicine, Stanford, CA
- Director, Obsessive-Compulsive Disorder Clinic, Stanford University School of Medicine, Stanford, CA
Dr. Aboujaoude is a psychiatrist and author based at Stanford University, where is the Director of the OCD Clinic. His clinical work, research and publications have focused on OCD, impulse control disorders and the intersection of technology and psychology. He is also the author of several books written for lay audiences on mental health issues. His work has been widely covered, including by The New York Times, The Wall Street Journal, Newsweek, TIME, CNN, and NPR.
Deepa Chand, MD
- Clinical Associate Professor of Nephrology, University of Illinois College of Medicine, Peoria, IL
Dr. Deepa Chand is a Board-Certified Pediatric Nephrologist with over 15 years of clinical, research, and teaching experience. She obtained her undergraduate Bachelor of Arts and Doctor of Medicine degrees from the University of Missouri at Kansas City. She also holds a Masters in Health Services Administration from Xavier University. After completing a residency in General Pediatrics at The Cleveland Clinic Foundation, she completed a fellowship in Pediatric Nephrology at Cincinnati Children’s Hospital Medical Center. She has held prestigious faculty positions at The Cleveland Clinic Foundation, Akron Children’s Hospital, and Rush University Medical Center. She has authored over 50 publications including co-editing “The Clinician’s Manual of Pediatric Nephrology”. She has received numerous teaching awards and community leadership recognition.
Kiki Chang, MD
- Professor of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, CA
- Director, Pediatric Bipolar Disorders Program & PANS Research Program, Luicille Packard Children’s Hospital, Palo Alto, CA
As Director of the Pediatric Bipolar Disorders Program, Dr. Chang conducts research into various facets of bipolar disorder. He is currently conducting phenomenologic, biologic, pharmacologic, and genetic studies of bipolar disorder in adults and children. These studies include brain imaging (MRI, MRS, fMRI) and medication and therapy trials. He is particularly interested in detecting prodromal bipolar disorder in children who might then be treated to prevent the development of full bipolar disorder. To do this, he has been studying children of parents with bipolar disorder who are at high risk for developing the disorder themselves.
As Director of the PANS Research Program, an offshoot of the PBDP, Dr. Chang is investigating underlying causes for the acute neuropsychiatric symptoms in these children. In conjunction with the PANS Clinic at LPCH, he is collecting phenomenological, immunologic, and brain imaging data, the first study ever to investigate this illness in this way.
Raj DasGupta, MD
- Assistant Professor of Clinical Medicine, Keck School of Medicine, Los Angeles, CA
Dr. Dasgupta completed his internal medicine residency at Michigan State University and his Pulmonary/Critical Care fellowship at Saint Lukes & Roosevelt Hospital then his sleep medicine fellowship at Henry Ford Hospital while working at VA Medical Center in Detroit. He received numerous awards including: resident of the year, fellow of the year and the Director’s Award for research two years in a row. After his training, Dr. Dasgupta worked at Abington Hospital where he was presented with the Faculty teacher of the year. Dr. Dasgupta is quadruple board certified in Internal Medicine, Pulmonary, Critical Care, and Sleep Medicine. Currently, Dr. Dasgupta is an Assistant Professor of Clinical Medicine at the University of Southern California. Dr. Dasgupta teaches USMLE Steps 1, 2, 3 for Kaplan Medical and writing his book “Medicine Morning Report: Beyond the Pearls” for Elsevier. Dr. Dasgupta can be seen on television shows such as “The Doctors” and “The Wellness Hour”.
Mark Frye, MD
- Professor of Psychiatry, Mayo Clinic, Rochester, MN
- Chair, Department of Psychiatry and Psychology, Mayo Clinic, Rochester MN
- Director, Mayo Clinic Depression Center, Rochester, MD
Dr. Frye received his medical degree from the University of Minnesota and completed his psychiatric training at the UCLA Neuropsychiatric Institute. He completed a subsequent research fellowship in the Biological Psychiatry Branch at the National Institute of Mental Health (NIMH) in Bethesda, Maryland. While at NIMH, his area of research was focusing on the neurobiology of depression and bipolar disorder. Formerly the Director of the UCLA Bipolar Disorder Research Program (1998-2006), he is now the Director of the Mayo Mood Clinic and Research Program.
His clinical interests are in bipolar disorder, depression, and alcoholism with a research focus on genomics, brain imaging, and neuroendocrinology of mood disorders and alcoholism.
Robert Hendren, DO
- Professor of Psychiatry and Behavioral Science, Division of Child and Adolescent Psychiatry, University of California, San Francisco (UCSF), San Francisco, CA
- Director, Division of Child and Adolescent Psychiatry, University of California, San Francisco (UCSF), San Francisco, CA
- Director, Neurodevelopmental, Translational Outcomes Research Program (NTORP)
Robert L. Hendren, D.O., is Professor of Psychiatry and Behavioral Science; Division of Child and Adolescent Psychiatry; Co-Director of the UCSF Dyslexia Center; and Director, Neurodevelopmental, Translational Outcomes Research Program (NTORP). He works in the STAR Autism and Neurodevelopmental Disorders Program. Dr. Hendren is Past President of the American Academy of Child and Adolescent Psychiatry (2007-2009). He has published over 100 scientific papers and 5 books and has been listed in “The Best Doctors in America”, each year since it was first published in 1996.
Dr. Hendren took his residency in general psychiatry at the Mayo Graduate School of Medicine, and his child and adolescent psychiatry fellowship at the Yale Child Study Center. He is board certified in General as well as Child and Adolescent Psychiatry. He has been on the faculty at the George Washington University School of Medicine, the University of New Mexico School of Medicine, and the University of Medicine and Dentistry of New Jersey (now Rutger’s) – Robert Wood Johnson and New Jersey Medical Schools. From 2001-2009, he was Professor of Psychiatry and Executive Director and Tsakopoulos-Vismara Chair at the University of California, Davis M.I.N.D. Institute (Medical Investigation of Neurodevelopmental Disorders).
His current areas of research and publication interests are translational interventional outcomes research including clinical pharmacology, nutraceutical and nutritional trials using biomarkers (MRI, measures of inflammation, oxidative stress, immune function and pharmacogenomics) to enhance resilience in neurodevelopmental disorders. He is currently applying a targeted outcomes research approach in a collaborative project with the Oak Hill School for youth with severe autism and neurodevelopmental spectrum disorders in San Anselmo, CA and at the Charles Armstrong School for youth with dyslexia in Belmont, CA.
Praveen Kambam, MD
- Assistant Clinical Professor in Psychiatry and Biobehavioral Sciences – David Geffen School of Medicine, UCLA, Los Angeles, CA
Dr. Kambam is currently in private practice in Los Angeles and is an Assistant Clinical Professor in Psychiatry and Biobehavioral Sciences at the David Geffen School of Medicine at UCLA. He is board certified in Forensic Psychiatry, General Psychiatry, Child and Adolescent Psychiatry, and Addiction Medicine. Dr. Kambam completed his residency training in psychiatry at the University of Michigan Health System and his subspecialty training in child and adolescent psychiatry at the UCLA Semel Institute. Dr. Kambam was then trained in forensic psychiatry by renowned forensic psychiatrist Philip J. Resnick, MD at Case Western Reserve University. Dr. Kambam’s academic interests include reducing the stigma associated with and improving access to mental health care through media, entertainment, and technology. He has presented at regional and national medical and popular culture conferences and authored numerous articles and book chapters.
W. Curt LaFrance, Jr., MD, MPH
- Director of Neuropsychiatry and Behavioral Neurology at Rhode Island Hospital Director, Alpert Medical School, Brown University, Providence, RI
- Associate Professor of Psychiatry and Neurology, Alpert Medical School, Brown University, Providence, RI
Dr. Lafrance is the neuropsychiatrist for the RIH Comprehensive Epilepsy Program, Staff Physician at the Providence VAMC, and a faculty member of the Brown Institute for Brain Science. He received a bachelor of arts degree in psychology from Wake Forest University, his medical degree from the Medical College of Georgia, and his master of public health from Brown University. He completed the combined residency in neurology and psychiatry at Brown, and he is boarded in both neurology and in psychiatry by the American Board of Psychiatry and Neurology. After residency, he completed a Clinical Research Fellowship in Combined Treatments at Brown University with an institutional NIH T-32 National Research Service Award. He is the recipient of awards, recognitions and grants, including the American Neuropsychiatric Association’s Career Development Award, the AAN’s Dreifuss-Penry Epilepsy Award, and Marquis’ Who’s Who in the World. He serves on the Epilepsy Foundation (EF) Professional Advisory Board, chaired American Epilepsy Society (AES) and International League Against Epilepsy (ILAE) Task Forces, and is a steward for the AES/NINDS Epilepsy Benchmarks. He has received grants from the EF, AES, Siravo Foundation, the VA and an NINDS K23 Award for treatment of nonepileptic seizures (5K23 NS045902).
Dr. LaFrance e has served as research advisor or mentor to psychiatry, neurology and neuropsychiatry residents and faculty and to undergraduates in neurobiology and psychology. He trains clinicians around the country using distance supervision in treatment delivery for seizures and somatoform disorders. His research interests focus on the neuropsychiatric aspects of epilepsy, conversion disorders and TBI. His studies are published in neurology and psychiatry journals. He served on the editorial boards of Epilepsy & Behavior and Epilepsia, and Journal of Neuropsychiatry and Clinical Neuroscience and is co-editor of the 3rd edition of Nonepileptic Seizures and co-author of Taking Control of Your Seizures: Workbook and Therapist Guide. A goal of his work at Brown, nationally and internationally has been to bridge neurology and psychiatry clinical practice and scientific research and to dissolve arbitrary boundaries between the two fields.
Matthew McCoyd, MD
- Assistant Professor of Neurology, Loyola University Chicago Stritch School of Medicine, Maywood, IL
- Assistant Neurology Residency Program Director, Loyola University Chicago Stritch School of Medicine, Maywood, IL
Dr. McCoyd completed a fellowship in clinical neurophysiology at University of Chicago before becoming a faculty member at Loyola, where he is also the assistant neurology residency program director. He is known as an exceptional speaker who presents outstanding, high-yield lectures.
Jeffrey Meadows, MD
- Associate Professor of Pediatric Cardiology, University of California, San Francisco (UCSF), San Francisco, CA
- Director, Pediatric Cardiopulmonary Exercise Testing Program, University of California, San Francisco (UCSF), San Francisco, CA
Dr. Jeffery Meadows is a pediatric cardiologist at UCSF Benioff Children’s Hospital who specializes in treating complex heart disease with interventional cardiac catheterization procedures. He treats infants and children as well as adults who have had heart conditions since birth. In the Pediatric Heart Center, he also is director of the Pediatric and Cardiopulmonary Congenital Exercise Laboratory, which tests heart and pulmonary function before, during and after exercise. Meadows treats pediatric heart conditions that exist at birth as well as conditions that develop later. His expertise includes atrial and ventricular septal defect closure, balloon angioplasty and valvuloplasty collateral vessel closure, endovascular stent placement, invasive physiologic assessment and angiography, and percutaneous pulmonary valve placement.
In his research, Meadows focuses on pediatric interventional cardiology and quantitative physiologic assessment of ventricular and vascular function, particularly in patients with complex single ventricle anatomy. Meadows is an assistant professor in Pediatric Cardiology at UCSF. He earned a medical degree at Johns Hopkins University and completed an internship and residency in pediatric internal medicine and fellowships in pediatric cardiology and pediatric interventional cardiology at Children’s Hospital in Boston.
Hani Nazha, MD
- Assistant Professor of Internal Medicine and Psychiatry, West Virginia University, Morgantown, WV
- Associate Program Director, Charleston Area Medical Center and West Virginia University, Internal Medicine and Psychiatry Program, Charleston, WV
- Director, Consult-Liaison Serve, Charleston Area Medical Center and West Virginia University, Charleston Division
Dr. Nazha Graduated from University of Damascus, School of Medicine in 2004. He worked on his Master Degree in Human Anatomy and Cell Biology especially in Neuroanatomy.
He completed the combined residency in Internal Medicine and Psychiatry at the Charleston Division of the WVU School of Medicine and Charleston Area Medical Center in 2012 and joined the faculty of the Internal Medicine and the Psychiatry Department in the same year as an Assistant Professor of Internal Medicine and Psychiatry.
He is interested in Psychosomatic Medicine, Anatomy of Neuropsychiatry and Psychopharmacology and rounds with residents and medical students on consult liaison service and on inpatient General Internal Medicine.
Charles B. Nemeroff, MD, PhD
- Leonard M. Miller Professor & Chairman, Department of Psychiatry and Behavioral Sciences, University of Miami Miller School of Medicine, Miami, FL
- Director, Center on Aging, University of Miami School of Medicine, Miami, FL
Dr. Nemeroff is a leading expert in the field of psychiatry. Over the last 30 years, Dr. Nemeroff has participated in more than 1000 invited lectures on topics such as the neurobiology of depression and anxiety, psychopharmacology, Post-traumatic stress disorder and the neurobiology of child abuse. Dr. Nemeroff, a distinguished fellow of the American Psychiatric Association (APA), is actively involved with numerous associations. He is a member of the APA Council of Research and chairs their task force for Biomarkers and Novel Treatments and the Research Colloquium for Junior Investigators.
He is a past president of the American College of Neuropsychopharmacology (ACNP) and the American College of Psychiatrists (ACP). Dr. Nemeroff serves on the Board of Directors of the American Foundation for Suicide Prevention (AFSP) and the Anxiety and Depression Association of America (ADAA). He is also on the Scientific Council of the Brain and Behavior Research Foundation (BBRF) formerly NARSAD and is a Member of The Institute of Medicine (IOM) of The National Academy of Sciences.
Dr. Nemeroff has published more than 1050 scholarly journal articles and more than 30 books, including Management of Treatment Resistant Psychiatric Disorders and four editions of Textbook of Psychopharmacology, with the 5th edition scheduled to appear this year. He is on the editorial board of several peer-reviewed journals including the Journal of Psychiatric Research, Depression and Anxiety, and the Journal of Neuropsychiatry and Clinical Neurosciences. He is the co-editor in chief of a new journal, Personalized Medicine in Psychiatry.
Douglas Noordsy, MD
- Clinical Professor of Psychiatry, Department of Psychiatry & Behavioral Sciences, Stanford University School of Medicine, Stanford, CA
- Director of Sports Psychiatry, Department of Psychiatry & Behavioral Sciences, Stanford University School of Medicine, Stanford, CA
- Co-Director, INSPIRE Early Psychosis Clinic, Department of Psychiatry & Behavioral Sciences, Stanford University School of Medicine, Stanford, CA
Douglas L. Noordsy, MD, is Clinical Professor, Director of Sports Psychiatry and Co-Director of the INSPIRE Early Psychosis Clinic in the Department of Psychiatry & Behavioral Sciences at Stanford University School of Medicine. Dr. Noordsy was previously Professor of Psychiatry, Director of Psychosis Services and Investigator, Psychopharmacology Research Group at the Geisel School of Medicine at Dartmouth. His research interests include medication and psychosocial treatments for individuals with psychotic disorders, including those with co-occurring substance use disorders; methods to facilitate recovery and promote achievement of optimal outcomes for people with schizophrenia and bipolar disorder; rehabilitation and recovery interventions (including cognitive behavioral therapy and physical exercise); and methods to prevent progression of early psychotic disorders.
Dr. Noordsy is a member of the Schizophrenia International Research Society, the International Early Psychosis Association, the American Medical Athletic Association, and the American Association of Community Psychiatrists, and is a fellow of the American Psychiatric Association. He is a member of the editorial advisory boards for Community Mental Health Journal, Case Reports in Psychiatry, American Medical Athletic Association Journal, and The Journal of Dual Diagnosis. Dr. Noordsy is the recipient of the Exemplary Psychiatrist Award from the National Alliance on Mental Illness in 2001.
Srinath Sanda, MD
- Associate Professor of Pediatrics, University of California, San Francisco, San Francisco, CA
Dr. Sanda is an Associate Professor of Pediatrics at UCSF. After completing his fellowship, Dr. Sanda took a joint faculty position at the University of Washington/Seattle Children’s Hospital and the Benaroya Research Institute, a national leader in translational research of autoimmune diseases. Dr. Sanda was responsible for enhancing translational immunology research into the pathogenesis of type 1 diabetes, caring for patients in diabetes clinical trials (including immune intervention and artificial pancreas studies), and developing his own clinical and laboratory research projects. He was recently awarded the Mark Pescovitz Early Career Patient Oriented Diabetes Research Award as well as a Career Development Award from the Juvenile Diabetes Research Foundation.
Dr. Sanda’s research interests center on the role of the immune system in pediatric diabetes, especially type 1 diabetes. Specifically, he is interested in the role of monocytes and innate inflammatory mediators such as IL-1β in cell migration, beta cell dysfunction, and the development of diabetes-related complications. These pathways may also be active in other forms of pediatric diabetes such as type 2 diabetes and cystic fibrosis-related diabetes (CFRD). Dr. Sanda’s lab analyzes human blood samples from patients with and without diabetes to understand the mechanisms of monocyte biology and to develop biomarkers useful in immune intervention trials for type 1 diabetes.
In addition, Dr. Sanda has begun to study genetic factors responsible for insulin secretion in type 1 diabetes. Specifically he has identified a genetic variant in the gene G6PC2 that may correlate with decline in insulin secretion over time in type 1 diabetes. Dr. Sanda plans to continue these preliminary studies by analyzing larger cohorts and conducting a broader analysis of genetic variants.
Charles Scott, MD
- Professor of Clinical Psychiatry, University of California, Davis, Davis, CA
- Chief, Division of Psychiatry and the Law, University of California, Davis, Davis, CA
- Training Director, Forensic Psychiatry Residency Program, University of California, Davis, Davis, CA
Dr. Scott is Chief, Division of Psychiatry and the Law, Forensic Psychiatry Training Director, and Professor of Clinical Psychiatry at the University of California, Davis Medical Center in Sacramento. He is board certified in Forensic Psychiatry, General Psychiatry, Child and Adolescent Psychiatry, and Addiction Psychiatry. He is the current president of the American Academy of Psychiatry and the Law (AAPL) and is also past-president of the Association of Directors of Forensic Psychiatric Fellowships. He has served as a member of the AAPL national task forces to develop guidelines for the evaluation of criminal responsibility and competency to stand trial. He is also one of the four AAPL Forensic Psychiatry Review Course Faculty instructors and in 2008 received the AAPL award as the most outstanding forensic psychiatry fellowship program instructor in the United States.
Dr. Scott has served as a forensic psychiatric consultant to jails, prisons, maximum security forensic inpatient units, and to the National Football League (NFL) providing training on violence risk assessment for NFL counselors. He has been editor and co-editor on four books related to forensic psychiatry and has published articles and book chapters in the areas of risk assessment of violence and aggression, the death penalty, juvenile violence, and mental health law. His research interests include the relationship of substance use to aggression among criminal defendants and on the quality of forensic evaluations of criminal responsibility. He lectures nationally on the topics of violence risk assessment, juvenile violence, substance use and violence, the assessment of sex offenders, correctional psychiatry, and malpractice issues in mental health.
Pam Rajendran Taub, MD
- Associate Professor of Medicine, University of California, San Diego, San Diego, CA
- Director of Step Family Cardiac Wellness and Rehabilitation Center, San Diego, CA
Dr. Pam Taub is an Associate Professor of Medicine in the Division of Cardiovascular Medicine at UC San Diego. She is the director of the Step Family Cardiac Wellness and Rehabilitation Center that will be located in the new UC San Diego Jacobs Medical Center opening in late 2016.
The mission of the Center is to actively engage patients and the community in prevention of cardiovascular disease. The Center will be conducting research on biomarkers and other diagnostics, wearable/mobile technologies that can improve patient outcomes.
Dr. Taub’s clinical practice focuses on preventive cardiology. She is consistently elected by her peers as a top doctor in San Diego Magazine’s “Physicians of Exceptional Excellence” annual survey.
She is active in clinical/translational research and is funded by the National Institutes of Health, Department of Defense, and American Heart Association. Her research focuses on biomarkers for cardiovascular risk factor stratification and in the examining the effects of epicatechin (a compound present in dark chocolate) on mitochondrial function/ cellular bioenergetics and exercise capacity in patients with heart failure and diabetes. She utilizes skeletal muscle biopsy and cardiopulmonary exercise testing to study mitochondrial function in patients with cardiac disease.
Dr. Taub received her medical degree at Boston University School of Medicine. She completed her internal medicine residency at the University of Washington Medical Center in Seattle and her fellowship in cardiology at UC San Diego.
John Walkup, MD
- Professor of Psychiatry, Weill Cornell Medical College & New York-Presbyterian Hospital, New York, NY
- Director, Division of Child & Adolescent Psychiatry, Weill Cornell Medical College & New York-Presbyterian Hospital, New York, NY
- Vice Chair, Psychiatry, Weill Cornell Medical College & New York-Presbyterian Hospital, New York, NY
Dr. Walkup has three main academic areas of interest. His work with Tourette syndrome, uniquely spans psychiatry, child psychiatry and neurology; his expertise in interventions research focuses on the development and evaluation of psychopharmacological and psychosocial treatments for the major psychiatric disorders of childhood including anxiety, depression, bipolar disorder, Tourette syndrome and suicidal behavior; and lastly, he has been involved in developing and evaluating interventions to reduce the large mental health disparities facing Native American youth, specifically drug use and suicide prevention.
Dr. Walkup has been awarded the Norbert and Charlotte Rieger Award for Academic Achievement in 2009 from the American Academy of Child and Adolescent Psychiatry and the Blanche F. Ittleson Award for Research in Child Psychiatry in 2011 from the American Psychiatric Association. His team at the Center for American Indian Health at Johns Hopkins won the Bronze Achievement Award from the Institute of Psychiatric Services of American Psychiatric Association in 2012 for the pioneering suicide prevention project on the White
Mountain Apache Reservation.
Dr. Walkup serves on the Scientific Advisory Boards of the Trichotillomania Learning Center and the Anxiety Disorders Association of America and the American Foundation of Suicide Prevention. He is also the Deputy Editor for Psychopharmacology for the Journal of the American Academy of Child and Adolescent Psychiatry. His research has been published in major medical journals including Journal of the American Medical Association and the New England Journal of Medicine, an unusual accomplishment for a child and adolescent psychiatrist.
Roger Weiss, MD
- Professor of Psychiatry, Harvard Medical School, Boston, MA
- Chief, Division of Alcohol and Drug Abuse, McLean Hospital, Belmont, MA
Dr. Weiss has received numerous awards in recognition of his work, including the 14th Annual H. David Archibald Award for Outstanding Research and/or Practice in the Addictions, Centre for Addiction and Mental Health, Toronto and Distinguished Fellow, American Psychiatric Association. Dr. Weiss serves as the Vice President of Greater Boston Council of Alcoholism and has served as a member of the Treatment Research Committee on the National Institute on Drug Abuse.
Dr. Weiss serves on the editorial board of numerous journals including the American Journal of Drug and Alcohol Abuse and is a reviewer for more than 15 scholarly medical journals. He has published more than 300 journal articles and book chapters, as well as researching in the field of alcohol and drug abuse for more than 25 years.
Amy Yule, MD
- Instructor of Psychiatry, Harvard Medical School, Boston, MA
Dr. Yule received her undergraduate degree from the University of California San Diego where she graduated cum laude. She attended the David Geffen School of Medicine at University of California Los Angeles. Dr. Yule completed her adult and child psychiatry training at Massachusetts General Hospital and McLean Hospital. She completed her addiction psychiatry training in the Partners Hospital program. Dr. Yule is now a staff child and adolescent psychiatrist in the Addiction Recovery Management Service and the West End Clinic at Massachusetts General Hospital. She is also an Instructor in Psychiatry at Harvard Medical School.
Dr. Yule was the 2012 recipient of the American Academy of Child and Adolescent Psychiatry Pilot Research Award for Junior Faculty supported by Eli Lilly USA, LLC. With support and mentorship from Dr. Wilens she has been involved in research examining risk factors for the development of adolescent substance use disorders, specifically risk associated with active parental substance use. Dr. Yule plans on continuing to be involved in clinical research focused on adolescent substance use disorders. She is particularly interested in decreasing risky behaviors in adolescent substance users. She hopes to improve identification of adolescent substance users at high risk for unintentional opioid overdose.